Allison Schwartz exercised Options for 320 BIO-RAD LABORATORIES shares at $0 per share across transactions dated 2026-09-05 and 2026-09-06, while a 2026-09-04 award added 719 derivative securities. The reported post-transaction holdings give investors the stated ownership picture: 1,768 shares and 185 derivative securities after the exercises.

Key Highlights

  • Allison Schwartz received 719 derivative securities from an award dated 4 September 2026.
  • Forfeiture entries were recorded at $386.11 per share, followed by reported ownership of 1,734 shares.
  • The 719 derivative securities award represented about 100.0% of Schwartz’s resulting derivative securities holding.

BIO-RAD LABORATORIES, INC. (NYSE: BIO) recorded option exercises covering 320 shares at $0 per share in transactions dated 5 September 2026 and 6 September 2026. Allison Schwartz, a director, held 1,768 shares after those exercises.

Option Exercises and Award Details

Schwartz also exercised options covering 320 derivative securities at $0 per share, with the resulting derivative securities holding reported at 185. A separate award dated 4 September 2026 involved 719 derivative securities. The award carried transaction code A, and Schwartz’s resulting derivative securities holding was reported at 719. Forfeiture entries spanning 5 September 2026 and 6 September 2026 were recorded at $386.11 per share.

Reported Ownership After Transactions

The award’s 719 derivative securities represented about 100.0% of Schwartz’s resulting derivative securities holding. The reported holdings were therefore stated separately for shares and derivative securities after the different transaction types. BIO-RAD LABORATORIES’ transaction records show the director’s post-exercise share holding at 1,768 and the post-exercise derivative securities holding at 185. The forfeiture entries were followed by a reported share holding of 1,734. Transaction code A denotes an award, grant, or other Acquisition from the company.